^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    SYHA1815

    i
    Other names: SYHA1815, SYHA-1815, SYHA 1815
    Associations
    News

    Trials

    Company:
    CSPC Pharma
    Drug class:
    FGFR inhibitor, RET inhibitor
    Related drugs:
    Associations
    News

    Trials

    Apply
    A Study to Investigate the Safety of SYHA1815 in Subjects With Unresectable Locally Advanced or Metastatic Solid Tumors (NCT05105464)
    Phase 1/2
    Shanghai Runshi Pharmaceutical Technology Co., Ltd
    Recruiting
    Last update posted :
    11/03/2021
    Initiation :
    06/25/2021
    Primary completion :
    09/01/2023
    Completion :
    09/01/2023
    PD-L1 • FGFR • KDR • CEACAM5 • FGF23
    |
    SYHA1815